Total Visits

Views
Efectividad y riesgos del tratamiento biológico con Natalizumab en esclerosis múltiple599

File Visits

Downloads
TFG-M-M1037.pdf373
TFG-M-M1037-ANEXO.pdf162

Select a period of time:

ViewsDownloads

Number of views in the range

Views
Efectividad y riesgos del tratamiento biológico con Natalizumab en esclerosis múltiple89

Number of downloads in the range

Downloads
TFG-M-M1037.pdf50
TFG-M-M1037-ANEXO.pdf13

Views

Views
April 20253
May 202527
June 202511
July 202515
August 202513
September 202515
October 20255
Download CSV file
 
Bar graph
 
Line graph

Number of downloads in the period of time

  • Downloads
  • April 2025
    13
  • May 2025
    13
  • June 2025
    7
  • July 2025
    15
  • August 2025
    3
  • September 2025
    9
  • October 2025
    3
 
Bar graph
 
Line graph

Top country views

Views
United States30
Spain12
Venezuela9
Russia9
China8
Hong Kong5
Ukraine4
India2
Brazil2
Argentina1

Top countries by downloads

Downloads
Spain14
United States12
China4
Venezuela1
Hong Kong1
Russia1
Brazil1
India1
Argentina1

Top cities views

Views
Inca8
Central5
Kyiv4
Valladolid2
Barcelona1
Beijing1
Boardman1
Buzau1
Cebu City1
Changsha1

Top cities by downloads

Downloads
Barcelona6
Inca2
Central1